Document is current
Any future updates will be listed below
-
Authors
Verweij, Laurens H. G. https://orcid.org/0009-0004-5556-0256
Kim, Seok-Young https://orcid.org/0000-0001-8566-839X
Laskaris, Dimitrios https://orcid.org/0000-0002-6177-0549
Lin, Lin https://orcid.org/0009-0001-6308-6804
van Son, Gijs J. F. https://orcid.org/0000-0003-0572-3243
Ringnalda, Femke C. A. S. https://orcid.org/0000-0002-0684-4613
Begthel, Harry
van Ineveld, Ravian L.
Winkel, Chris
Slack, Jay P.
Rios, Anne C. https://orcid.org/0000-0002-9082-8068
Sanders, Karin https://orcid.org/0000-0001-9634-9853
van Rheenen, Jacco https://orcid.org/0000-0001-8175-1647
van de Wetering, Marc https://orcid.org/0000-0002-8195-9939
Clevers, Hans https://orcid.org/0000-0002-3077-5582
- License Information
-
More Information
Article History
Received: 20 August 2024
Accepted: 6 October 2025
First Online: 21 November 2025
Competing interests
: J.S. is an employee and shareholder of GIVAUDAN – C.W. is an employee of GIVAUDAN. H.C. is listed as an inventor on patents related to organoid technology held by the Royal Netherlands Academy of Arts and Sciences. He is currently Head of Pharma Research and Early Development at Roche, Basel, Switzerland. A full disclosure is available at . All other authors declare that they have no competing interests.
